CRISPR/Cas9 und Autoimmunerkrankungen: Bearbeiten von Genen zur Modulation der Immunität
CRISPR/Cas9 gene editing technology holds promise for treating autoimmune diseases by modulating immune responses. By precisely targeting specific genes, CRISPR/Cas9 can correct genetic defects, suppress overactive immune cells, and promote immune tolerance. This innovative approach offers potential for personalized treatments and improved outcomes in autoimmune disorders.












